Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Awareness and Interest in Uterus Transplantation Over Time: Analysis of Those Seeking Surgical Correction for Uterine-Factor Infertility in the US

Version 1 : Received: 11 May 2023 / Approved: 12 May 2023 / Online: 12 May 2023 (14:41:29 CEST)

A peer-reviewed article of this Preprint also exists.

Johannesson, L.; Testa, G.; Beshara, M.M.; da Graca, B.; Walter, J.R.; Quintini, C.; Latif, N.; Hashimoto, K.; Richards, E.G.; O’Neill, K. Awareness and Interest in Uterus Transplantation over Time: Analysis of Those Seeking Surgical Correction for Uterine-Factor Infertility in the US. J. Clin. Med. 2023, 12, 4201. Johannesson, L.; Testa, G.; Beshara, M.M.; da Graca, B.; Walter, J.R.; Quintini, C.; Latif, N.; Hashimoto, K.; Richards, E.G.; O’Neill, K. Awareness and Interest in Uterus Transplantation over Time: Analysis of Those Seeking Surgical Correction for Uterine-Factor Infertility in the US. J. Clin. Med. 2023, 12, 4201.

Abstract

This study describes the characteristics of women who contacted an active program performing uterus transplantation (UTx) in the US expressing interest in becoming a uterus transplant recipient or a living donor. Basic demographic and self-reported clinical information was collected from women who contacted any of the three US UTx programs from 2015 to July 2022. The three centers received 5194 inquiries about becoming a UTx recipient during the study timeframe. Among those reporting a cause of infertility, almost all (4066/4331, 94%) were absence of a uterus, either congenitally (794/4066, 20%) or secondary to hysterectomy (3272/4066, 80%). The mean age was 34 years, and 49% (2545/5194) had at least one child at the time of application. The two centers using living donors received 2217 inquiries about becoming living donors. The mean age was 34 years, and 60% (1330/2217) had given birth to ≥1 child. While most of the UTx clinical trial evidence has focused on young women with congenital absence of the uterus, these results show interest from a much broader patient population in terms of age, cause of infertility, and parity. These results raise questions about whether and to what extent the indications and eligibility criteria for UTx should be expanded as the procedure transitions from the experimental phase to being offered as a clinical treatment.

Keywords

uterus transplantation; recipient; living donor; hysterectomy; infertility; parity

Subject

Medicine and Pharmacology, Obstetrics and Gynaecology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.